LifeMD logo
LifeMD LFMD
$ 3.45 -4.43%

Quarterly report 2025-Q3
added 11-17-2025

report update icon

LifeMD Retained Earnings 2011-2025 | LFMD

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.
Possible uses include
  • reinvestment in development (R&D, equipment, marketing)
  • debt repayment
  • acquisition of other companies
  • creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings LifeMD

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-214 M -191 M -142 M -80.2 M -16.6 M -12.1 M -10.9 M -9.69 M -8.59 M -8.52 M -8.06 M -7.8 M -7.35 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-7.35 M -214 M -55.1 M

Quarterly Retained Earnings LifeMD

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-248 M -238 M -236 M -240 M -235 M -229 M -222 M -214 M -210 M -203 M -195 M -191 M -178 M -170 M -156 M -142 M -123 M -109 M -91.8 M -80.2 M -80.2 M -80.2 M -80.2 M -16.6 M -16.6 M -16.6 M -16.6 M -12.1 M -12.1 M -12.1 M -12.1 M -10.9 M -10.9 M -10.9 M -10.9 M -9.69 M -9.69 M -9.69 M -9.69 M -8.59 M -8.59 M -8.59 M -8.59 M -8.52 M -8.52 M -8.52 M -8.52 M -8.06 M -8.06 M -8.06 M -8.06 M -7.8 M -7.8 M -7.8 M -7.8 M - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-7.8 M -248 M -77.8 M

Retained Earnings of other stocks in the Pharmaceutical retailers industry

Issuer Retained Earnings Price % 24h Market Cap Country
Аптеки 36.6 Аптеки 36.6
APTK
-55.2 B - - - russiaRussia
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.
CJJD
-36.4 M - -5.59 % $ 49.9 M chinaChina
Trxade Group Trxade Group
MEDS
-33.2 M - 4.55 % $ 5.8 M usaUSA
Greenlane Holdings Greenlane Holdings
GNLN
-225 M $ 2.99 -3.24 % $ 22.5 M usaUSA
PetMed Express PetMed Express
PETS
66.5 M $ 3.02 70.69 % $ 62.2 M usaUSA
BOQI International Medical BOQI International Medical
BIMI
-70.1 M - 6.33 % $ 5.86 M chinaChina
Rite Aid Corporation Rite Aid Corporation
RAD
-6.55 B - - $ 35.5 M usaUSA
111 111
YI
-3.88 B $ 3.7 -4.15 % $ 636 M chinaChina
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
23.3 B - - $ 10.3 B usaUSA